A citation-based method for searching scientific literature

Angela De Iuliis, Ennio Montinaro, Giuseppe Fatati, Mario Plebani, Carlo Colosimo. Neural Regen Res 2022
Times Cited: 3







List of co-cited articles
30 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease.
Peng Feng, Xiangjian Zhang, Dongfang Li, Chenhui Ji, Ziyue Yuan, Ruifang Wang, Guofang Xue, Guanglai Li, Christian Hölscher. Neuropharmacology 2018
60
66

A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
Hong-Yan Cai, Dan Yang, Jing Qiao, Jun-Ting Yang, Zhao-Jun Wang, Mei-Na Wu, Jin-Shun Qi, Christian Hölscher. J Alzheimers Dis 2021
9
66

The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease.
Caitriona M Long-Smith, Sean Manning, Paula L McClean, Meghan F Coakley, Domhnall J O'Halloran, Christian Holscher, Cora O'Neill. Neuromolecular Med 2013
112
66

A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain.
Lijun Cao, Dongfang Li, Peng Feng, Lin Li, Guo-Fang Xue, Guanglai Li, Christian Hölscher. Neuroreport 2016
53
66

How does brain insulin resistance develop in Alzheimer's disease?
Fernanda G De Felice, Mychael V Lourenco, Sergio T Ferreira. Alzheimers Dement 2014
216
66




Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer's Disease and Type 2 Diabetes.
Maria Jose Carranza-Naval, Angel Del Marco, Carmen Hierro-Bujalance, Pilar Alves-Martinez, Carmen Infante-Garcia, Maria Vargas-Soria, Marta Herrera, Belen Barba-Cordoba, Isabel Atienza-Navarro, Simon Lubian-Lopez,[...]. Front Aging Neurosci 2021
5
66


The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem.
Elvira Alvarez, M Dolores Martínez, Isabel Roncero, Julie A Chowen, Beatriz García-Cuartero, Juan D Gispert, Carmen Sanz, Patricia Vázquez, Antonio Maldonado, Javier de Cáceres,[...]. J Neurochem 2005
182
66

In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
Michael Gejl, Albert Gjedde, Lærke Egefjord, Arne Møller, Søren B Hansen, Kim Vang, Anders Rodell, Hans Brændgaard, Hanne Gottrup, Anna Schacht,[...]. Front Aging Neurosci 2016
220
66



A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
Ziyue Yuan, Dongfang Li, Peng Feng, Guofang Xue, Chenhui Ji, Guanglai Li, Christian Hölscher. Eur J Pharmacol 2017
58
66

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, Gail Busza, Clive Holmes, Craig Ritchie, Robert Lawrence, Brady McFarlane, George Tadros, Basil H Ridha,[...]. Trials 2019
83
66



Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control.
Young-Sun Lee, Hee-Sook Jun. Mediators Inflamm 2016
206
66


The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer's Disease.
Mark Maskery, Elizabeth Mary Goulding, Simon Gengler, Josefine Ulrikke Melchiorsen, Mette Marie Rosenkilde, Christian Hölscher. Am J Alzheimers Dis Other Demen 2020
17
66

Semaglutide lowers body weight in rodents via distributed neural pathways.
Sanaz Gabery, Casper G Salinas, Sarah J Paulsen, Jonas Ahnfelt-Rønne, Tomas Alanentalo, Arian F Baquero, Stephen T Buckley, Erzsébet Farkas, Csaba Fekete, Klaus S Frederiksen,[...]. JCI Insight 2020
121
66

Anti-Obesity Therapy: from Rainbow Pills to Polyagonists.
T D Müller, C Clemmensen, B Finan, R D DiMarchi, M H Tschöp. Pharmacol Rev 2018
84
66

Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.
Geisa Nogueira Salles, Michele Longoni Calió, Christian Hölscher, Cristina Pacheco-Soares, Marimelia Porcionatto, Anderson Oliveira Lobo. Neuropharmacology 2020
22
66


Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
Martina Holubová, Lucie Hrubá, Andrea Popelová, Michal Bencze, Veronika Pražienková, Simon Gengler, Helena Kratochvílová, Martin Haluzík, Blanka Železná, Jaroslav Kuneš,[...]. Neuropharmacology 2019
35
66

Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.
Therese S Salameh, Elizabeth M Rhea, Konrad Talbot, William A Banks. Biochem Pharmacol 2020
29
66

The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.
Andre F Batista, Leticia Forny-Germano, Julia R Clarke, Natalia M Lyra E Silva, Jordano Brito-Moreira, Susan E Boehnke, Andrew Winterborn, Brian C Coe, Ann Lablans, Juliana F Vital,[...]. J Pathol 2018
132
66

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study.
Henry A Feldman, Christopher Longcope, Carol A Derby, Catherine B Johannes, Andre B Araujo, Andrea D Coviello, William J Bremner, John B McKinlay. J Clin Endocrinol Metab 2002
33

Neuromelanic pigment in substantia nigra neurons of rats and dogs.
M DeMattei, A C Levi, R G Fariello. Neurosci Lett 1986
34
33

Increases in TH immunoreactivity, neuromelanin and degeneration in the substantia nigra of middle aged mice.
Sung Tae Kim, Ji Hyun Choi, Donghou Kim, Onyou Hwang. Neurosci Lett 2006
14
33

Inhibin is an important factor in the regulation of FSH secretion in the adult male hamster.
H Kishi, M Itoh, S Wada, Y Yukinari, Y Tanaka, N Nagamine, W Jin, G Watanabe, K Taya. Am J Physiol Endocrinol Metab 2000
26
33

A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers.
Rodrigo Cataldi, Sean Chia, Katarina Pisani, Francesco S Ruggeri, Catherine K Xu, Tomas Šneideris, Michele Perni, Sunehera Sarwat, Priyanka Joshi, Janet R Kumita,[...]. Commun Biol 2021
12
33

Effects of caloric restriction on monoaminergic neurotransmission, peripheral hormones, and olfactory memory in aged rats.
Divka Rojic-Becker, Marta Portero-Tresserra, Margarita Martí-Nicolovius, Anna Vale-Martínez, Gemma Guillazo-Blanch. Behav Brain Res 2021
2
50

Origin and Evolution of the Neuroendocrine Control of Reproduction in Vertebrates, With Special Focus on Genome and Gene Duplications.
Sylvie Dufour, Bruno Quérat, Hervé Tostivint, Catherine Pasqualini, Hubert Vaudry, Karine Rousseau. Physiol Rev 2020
31
33

Changes in monoamines and their metabolite levels in some brain regions of aged rats.
F Ponzio, G Calderini, G Lomuscio, G Vantini, G Toffano, S Algeri. Neurobiol Aging 1982
144
33

Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolites in presenescent older rats.
P G MacRae, W W Spirduso, T J Walters, R P Farrar, R E Wilcox. Psychopharmacology (Berl) 1987
91
33

Loss of Brain Norepinephrine Elicits Neuroinflammation-Mediated Oxidative Injury and Selective Caudo-Rostral Neurodegeneration.
Sheng Song, Lulu Jiang, Esteban A Oyarzabal, Belinda Wilson, Zibo Li, Yen-Yu Ian Shih, Qingshan Wang, Jau-Shyong Hong. Mol Neurobiol 2019
33
33


Inflammaging, hormesis and the rationale for anti-aging strategies.
Aurelia Santoro, Morena Martucci, Maria Conte, Miriam Capri, Claudio Franceschi, Stefano Salvioli. Ageing Res Rev 2020
28
33

Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem.
M T Herrero, E C Hirsch, A Kastner, M R Luquin, F Javoy-Agid, L M Gonzalo, J A Obeso, Y Agid. Dev Neurosci 1993
19
33

Induction of lipid peroxidation during steroidogenesis in the rat testis.
V Peltola, I Huhtaniemi, T Metsa-Ketela, M Ahotupa. Endocrinology 1996
141
33

Locus coeruleus-norepinephrine: basic functions and insights into Parkinson's disease.
Bilal Abdul Bari, Varun Chokshi, Katharina Schmidt. Neural Regen Res 2020
22
33





An Overview of the Role of Lipofuscin in Age-Related Neurodegeneration.
Alexandra Moreno-García, Alejandra Kun, Olga Calero, Miguel Medina, Miguel Calero. Front Neurosci 2018
126
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.